{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:04:57Z","timestamp":1776866697859,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,28]]},"DOI":"10.7759\/cureus.68002","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T10:20:04Z","timestamp":1724840404000},"source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Tarique","family":"Aziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh K","family":"Niraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo P","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346:1221-31. 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000539","article-title":"Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?","volume":"22","author":"Spooner MH","year":"2019","unstructured":"Spooner MH, Jump DB. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?. Curr Opin Clin Nutr Metab Care. 2019, 22:103-10. 10.1097\/MCO.0000000000000539","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia","volume":"14","author":"Zhu FS","year":"2008","unstructured":"Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol. 2008, 14:6395-400. 10.3748\/wjg.14.6395","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.05.006","article-title":"The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis","volume":"16","author":"Pagadala MR","year":"2012","unstructured":"Pagadala MR, McCullough AJ. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis. 2012, 16:487-504. 10.1016\/j.cld.2012.05.006","journal-title":"Clin Liver Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1665-2681(19)31825-3","article-title":"Nonalcoholic fatty liver disease and its association with cardiovascular disease","volume":"8 Suppl 1","author":"Lizardi-Cervera J","year":"2009","unstructured":"Lizardi-Cervera J, Aguilar-Zapata D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol. 2009, 8 Suppl 1:S40-3. 10.1016\/s1665-2681(19)31825-3","journal-title":"Ann Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher G","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010, 363:1341-50. 10.1056\/NEJMra0912063","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12352","article-title":"Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis","volume":"38","author":"Hoofnagle JH","year":"2013","unstructured":"Hoofnagle JH, Van Natta ML, Kleiner DE, et al.. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2013, 38:134-43. 10.1111\/apt.12352","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.2169","article-title":"Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes","volume":"53","author":"Tiikkainen M","year":"2004","unstructured":"Tiikkainen M, H\u00e4kkinen AM, Korsheninnikova E, Nyman T, M\u00e4kimattila S, Yki-J\u00e4rvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes. 2004, 53:2169-76. 10.2337\/diabetes.53.8.2169","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal AJ","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, et al.. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010, 362:1675-85. 10.1056\/NEJMoa0907929","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-416003-3.00013-5","article-title":"Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid","volume":"65","author":"Siriwardhana N","year":"2012","unstructured":"Siriwardhana N, Kalupahana NS, Moustaid-Moussa N. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res. 2012, 65:211-22. 10.1016\/B978-0-12-416003-3.00013-5","journal-title":"Adv Food Nutr Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-food-111317-095850","article-title":"Omega-3 polyunsaturated fatty acids and their health benefits","volume":"9","author":"Shahidi F","year":"2018","unstructured":"Shahidi F, Ambigaipalan P. Omega-3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol. 2018, 9:345-81. 10.1146\/annurev-food-111317-095850","journal-title":"Annu Rev Food Sci Technol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2777-0","article-title":"Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials","volume":"19","author":"Yang SJ","year":"2019","unstructured":"Yang SJ, Chi CC. Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials. BMC Complement Altern Med. 2019, 19:354. 10.1186\/s12906-019-2777-0","journal-title":"BMC Complement Altern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya J","year":"2004","unstructured":"Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2004, 106:635-43. 10.1042\/CS20030326","journal-title":"Clin Sci (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000327785","article-title":"Importance of the omega-6\/omega-3 balance in health and disease: evolutionary aspects of diet","volume":"102","author":"Simopoulos AP","year":"2011","unstructured":"Simopoulos AP. Importance of the omega-6\/omega-3 balance in health and disease: evolutionary aspects of diet. World Rev Nutr Diet. 2011, 102:10-21. 10.1159\/000327785","journal-title":"World Rev Nutr Diet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/md12020964","article-title":"Dietary fucoxanthin increases metabolic rate and upregulated mRNA expressions of the PGC-1alpha network, mitochondrial biogenesis and fusion genes in white adipose tissues of mice","volume":"12","author":"Wu MT","year":"2014","unstructured":"Wu MT, Chou HN, Huang CJ. Dietary fucoxanthin increases metabolic rate and upregulated mRNA expressions of the PGC-1alpha network, mitochondrial biogenesis and fusion genes in white adipose tissues of mice. Mar Drugs. 2014, 12:964-82. 10.3390\/md12020964","journal-title":"Mar Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1459790","article-title":"Effects of omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis","volume":"2016","author":"Lu W","year":"2016","unstructured":"Lu W, Li S, Li J, et al.. Effects of omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis. Gastroenterol Res Pract. 2016, 2016:1459790. 10.1155\/2016\/1459790","journal-title":"Gastroenterol Res Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092769","article-title":"Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis","volume":"12","author":"Lee CH","year":"2020","unstructured":"Lee CH, Fu Y, Yang SJ, Chi CC. Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis. Nutrients. 2020, 12:2769. 10.3390\/nu12092769","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1192099","article-title":"Omega-3 intake is associated with liver disease protection","volume":"11","author":"Vell MS","year":"2023","unstructured":"Vell MS, Creasy KT, Scorletti E, et al.. Omega-3 intake is associated with liver disease protection. Front Public Health. 2023, 11:1192099. 10.3389\/fpubh.2023.1192099","journal-title":"Front Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100278","article-title":"Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver: a randomized double-blind clinical trial","volume":"19","author":"Orang Z","year":"2020","unstructured":"Orang Z, Mohsenpour MA, Mozaffari-Khosravi H. Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver: a randomized double-blind clinical trial. Obes Med. 2020, 19:100278. 10.1016\/j.obmed.2020.100278","journal-title":"Obes Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105074","article-title":"Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"92","author":"Farhangi MA","year":"2022","unstructured":"Farhangi MA, Dehghan P, Musazadeh V, Kavyani M, Maleki P. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. J Func Foods. 2022, 92:105074. 10.1016\/j.jff.2022.105074","journal-title":"J Func Foods"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2018.08.003","article-title":"Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study","volume":"12","author":"Oscarsson J","year":"2018","unstructured":"Oscarsson J, \u00d6nnerhag K, Ris\u00e9rus U, et al.. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study. J Clin Lipidol. 2018, 12:1390-403.e4. 10.1016\/j.jacl.2018.08.003","journal-title":"J Clin Lipidol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.06.015","article-title":"Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"44","author":"Sangouni AA","year":"2021","unstructured":"Sangouni AA, Orang Z, Mozaffari-Khosravi H. Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. Clin Nutr ESPEN. 2021, 44:130-5. 10.1016\/j.clnesp.2021.06.015","journal-title":"Clin Nutr ESPEN"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114520000495","article-title":"Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial","volume":"123","author":"Song L","year":"2020","unstructured":"Song L, Zhao XG, Ouyang PL, et al.. Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial. Br J Nutr. 2020, 123:1148-58. 10.1017\/S0007114520000495","journal-title":"Br J Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020475","article-title":"Effect of fish oil supplementation on hepatic and visceral fat in overweight men: a randomized controlled trial","volume":"11","author":"Parker HM","year":"2019","unstructured":"Parker HM, Cohn JS, O'Connor HT, Garg ML, Caterson ID, George J, Johnson NA. Effect of fish oil supplementation on hepatic and visceral fat in overweight men: a randomized controlled trial. Nutrients. 2019, 11:475. 10.3390\/nu11020475","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson JW","year":"2018","unstructured":"Eriksson JW, Lundkvist P, Jansson PA, et al.. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia. 2018, 61:1923-34. 10.1007\/s00125-018-4675-2","journal-title":"Diabetologia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2642714","article-title":"Protective effect of Phaleria macrocarpa water extract (proliverenol) against carbon tetrachloride-induced liver fibrosis in rats: role of TNF-\u03b1 and TGF-\u03b21","volume":"2018","author":"Sundari N","year":"2018","unstructured":"Sundari N, Soetikno V, Louisa M, Wardhani BW, Tjandrawinata RR. Protective effect of Phaleria macrocarpa water extract (proliverenol) against carbon tetrachloride-induced liver fibrosis in rats: role of TNF-\u03b1 and TGF-\u03b21. J Toxicol. 2018, 2018:2642714. 10.1155\/2018\/2642714","journal-title":"J Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2020.4929","article-title":"Antifibrotic activity of Phaleria macrocarpa extract in rat liver-fibrosis model: focus on oxidative stress markers, TGF-\u03b21 and MMP-13","volume":"8","author":"Wardhani BW","year":"2020","unstructured":"Wardhani BW, Sundari N, Tjandrawinata RR, Jusuf AA, Soetikno V, Louisa M. Antifibrotic activity of Phaleria macrocarpa extract in rat liver-fibrosis model: focus on oxidative stress markers, TGF-\u03b21 and MMP-13. Open Acc Macedonian J Med Sci. 2020, 8:555-62. 10.3889\/oamjms.2020.4929","journal-title":"Open Acc Macedonian J Med Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids","volume":"58","author":"Spahis S","year":"2018","unstructured":"Spahis S, Alvarez F, Ahmed N, et al.. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. J Nutr Biochem. 2018, 58:28-36. 10.1016\/j.jnutbio.2018.03.025","journal-title":"J Nutr Biochem"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113372","article-title":"Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial","volume":"12","author":"Cansan\u00e7\u00e3o K","year":"2020","unstructured":"Cansan\u00e7\u00e3o K, Citelli M, Carvalho Leite N, L\u00f3pez de Las Hazas MC, D\u00e1valos A, Tavares do Carmo MD, Peres WA. Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial. Nutrients. 2020, 12:3372. 10.3390\/nu12113372","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1906","article-title":"Effect of omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD","volume":"6","author":"\u0160m\u00edd V","year":"2022","unstructured":"\u0160m\u00edd V, Dvo\u0159\u00e1k K, \u0160ediv\u00fd P, et al.. Effect of omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD. Hepatol Commun. 2022, 6:1336-49. 10.1002\/hep4.1906","journal-title":"Hepatol Commun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002297","article-title":"Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"34","author":"Musazadeh V","year":"2022","unstructured":"Musazadeh V, Dehghan P, Khoshbaten M. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol. 2022, 34:537-45. 10.1097\/MEG.0000000000002297","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu10081126","article-title":"Evaluation of a high concentrate omega-3 for correcting the omega-3 fatty acid nutritional deficiency in non-alcoholic fatty liver disease (CONDIN)","volume":"10","author":"Tobin D","year":"2018","unstructured":"Tobin D, Brevik-Andersen M, Qin Y, Innes JK, Calder PC. Evaluation of a high concentrate omega-3 for correcting the omega-3 fatty acid nutritional deficiency in non-alcoholic fatty liver disease (CONDIN). Nutrients. 2018, 10:1126. 10.3390\/nu10081126","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.334.12315","article-title":"The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: a systematic review and meta-analysis of RCTs","volume":"33","author":"Yu L","year":"2017","unstructured":"Yu L, Yuan M, Wang L. The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: a systematic review and meta-analysis of RCTs. Pak J Med Sci. 2017, 33:1022-8. 10.12669\/pjms.334.12315","journal-title":"Pak J Med Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-022-00826-5","article-title":"Effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials","volume":"22","author":"Khorshidi M","year":"2023","unstructured":"Khorshidi M, Hazaveh ZS, Alimohammadi-Kamalabadi M, et al.. Effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials. Nutr J. 2023, 22:9. 10.1186\/s12937-022-00826-5","journal-title":"Nutr J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102487","article-title":"Effect of omega-3 fatty acids supplementation on anthropometric indices in children and adolescents: a systematic review and meta-analysis of randomized controlled trials","volume":"53","author":"Jazayeri S","year":"2020","unstructured":"Jazayeri S, Heshmati J, Mokhtari Z, Sepidarkish M, Nameni G, Potter E, Zaroudi M. Effect of omega-3 fatty acids supplementation on anthropometric indices in children and adolescents: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020, 53:102487. 10.1016\/j.ctim.2020.102487","journal-title":"Complement Ther Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286255-effectiveness-of-omega-3-polyunsaturated-fatty-acids-in-non-alcoholic-fatty-liver-disease-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T10:20:19Z","timestamp":1724840419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286255-effectiveness-of-omega-3-polyunsaturated-fatty-acids-in-non-alcoholic-fatty-liver-disease-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.68002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}